We studied the activation pattern of clotting, fibrinolysis, and kinin-kallikrein during the first 5 d of life in 10 preterm infants with signs of severe idiopathic respiratory distress syndrome (IRDS) after birth (IRDS group) and in 12 healthy preterm infants (reference group). We found systemic activation of clotting, fibrinolysis, and kininkallikrein in the IRDS infants within 12 to 24 h of birth, represented by increased median thrombin-antithrombin I11 complex formation (90 ng/mL versus 10 ng/mL in the reference group, p < 0.05), increased mean tissue-type plasminogen activator plasma concentrations (11.8 ng/mL versus 3.5 ng/mL in the reference group, p < 0.05), and increased mean plasma kallikrein activity (182.6% versus 162.0% of maximal activated human plasma in the reference group,p < 0.05), respectively. Clotting activation was accompanied by a significant decrease of the platelet count. Clotting and fibrinolytic activity decreased in the IRDS group during the first 2 to 3 d of life. Kinin-kallikrein activation was accompanied by decreased plasma kallikrein inhibitor activity values and did not change throughout the study period. Plasma factor XI1 activity was not significantly increased in the IRDS infants during the first 2 d of life but did significantly increase thereafter. The cause of simultaneous activation of clotting, fibrinolysis, and kinin-kallikrein in our IRDS infants has not yet been clarified. However, this activation process may contribute to lung injury such as that described in the adult respiratory distress syndrome.(Pediatr Res 36: 647-653, 1994) Abbreviations IRDS, idiopathic respiratory distress syndrome CPP, cryoglobulin poor plasma AT 111, antithrombin 111 T-AT 111, thrombin-antithrombin I11 F XIIa, factor XI1 activity t-PA, tissue-type plasminogen activator PKKI, plasma kallikrein inhibitor activity % AHP, percentage of maximal activated human plasma % NHP, percentage of normal human plasma Intraalveolar and intravascular deposition of fibrin has been found in preterm infants suffering from IRDS (1, 2). These fibrin depositions are likely to contribute to respiratory insufficiency. Intraalveolar fibrin, a major component of hyaline membranes, inactivates considerable amounts of surfactant (1-3). Intravascular fibrin, found at autopsy in the lungs of preterm infants who died of severe IRDS, decreases surfactant synthesis due to impaired lung perfusion (1, 2). These intraalveolar and intravascular fibrin depositions are the result of activation of the clotting system represented